F. Skoulidis, K. Cuppens, A. Sacher, V. Velcheti, D.H. Lee, M.T. Lin, T.M. Fernando, S. Li, D. Bradley, M. Z. Crnkovic, M.S. Mathisen
{"title":"157TiP Krascendo-170 肺癌:一项针对未经治疗的 KRAS G12C+ 晚期非小细胞肺癌 (NSCLC) 的 divarasib + pembrolizumab ± 铂类化疗和培美曲塞的 Ib/II 期研究","authors":"F. Skoulidis, K. Cuppens, A. Sacher, V. Velcheti, D.H. Lee, M.T. Lin, T.M. Fernando, S. Li, D. Bradley, M. Z. Crnkovic, M.S. Mathisen","doi":"10.1016/j.iotech.2023.100668","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":192507,"journal":{"name":"Immuno-Oncology and Technology","volume":"118 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"157TiP Krascendo-170 Lung: A phase Ib/II study of divarasib + pembrolizumab ± platinum-based chemotherapy and pemetrexed in untreated KRAS G12C+ advanced non-small cell lung cancer (NSCLC)\",\"authors\":\"F. Skoulidis, K. Cuppens, A. Sacher, V. Velcheti, D.H. Lee, M.T. Lin, T.M. Fernando, S. Li, D. Bradley, M. Z. Crnkovic, M.S. Mathisen\",\"doi\":\"10.1016/j.iotech.2023.100668\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":192507,\"journal\":{\"name\":\"Immuno-Oncology and Technology\",\"volume\":\"118 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-12-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Immuno-Oncology and Technology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1016/j.iotech.2023.100668\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Immuno-Oncology and Technology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/j.iotech.2023.100668","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
157TiP Krascendo-170 Lung: A phase Ib/II study of divarasib + pembrolizumab ± platinum-based chemotherapy and pemetrexed in untreated KRAS G12C+ advanced non-small cell lung cancer (NSCLC)